Rapid Micro Biosystems to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

LEXINGTON, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the Morgan Stanley 22^nd Annual Global Healthcare Conference on Friday, September 6, 2024, in New York City.

Read more at globenewswire.com